Growth-differentiation factor-15 and functional outcome after acute ischemic stroke

Autor: Rosine Lahno, Katrin Wasser, Beatrice Haase, Klaus Gröschel, Mark Weber-Krüger, Joachim Seegers, Raoul Stahrenberg, Cord-Friedrich Niehaus, Dirk Vollmann, Sonja Schnaudigel, Rolf Wachter, Frank T. Edelmann, Janin Wohlfahrt
Jazyk: angličtina
Předmět:
Zdroj: Journal of Neurology
ISSN: 0340-5354
DOI: 10.1007/s00415-011-6379-0
Popis: Blood biomarkers may improve the performance in predicting early stroke outcome beyond well-established clinical factors. We investigated the value of growth-differentiation factor-15 (GDF-15) to predict functional outcome after 90 days in a prospectively collected patient cohort with symptoms of acute ischemic stroke. Two hundred eighty-one patients with symptoms of acute ischemic stroke were prospectively investigated. Serial blood samples for GDF-15 analysis were obtained after the admission of the patient, after 6 and 24 h. Primary outcome was the dichotomized modified ranking scale (MRS) 90 days after the initial clinical event. Within the final study population (264 patients, mean age 70.3 ± 12.7 years, 55.3% male), National Institutes of Health Stroke Scale (NIH-SS) [odds ratio (OR) 1.269, 95% confidence interval (CI) 1.141–1.412, p
Databáze: OpenAIRE